Prevalence of comorbidities and concomitant medication use in acromegaly: analysis of real-world data from the United States.

Maria FleseriuAriel BarkanMaria Del Pilar SchneiderYannis DarhiAmicie de PierrefeuAntonio Ribeiro-OliveiraStephan PetersennSebastian NeggersShlomo Melmed

Published in: Pituitary (2022)

Compared with patients without acromegaly, patients with acromegaly have significantly more comorbidities and are prescribed significantly more concomitant medications. Physicians should consider the number and type of ongoing medications for individual patients before prescribing additional acromegaly treatments.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
primary care
chronic kidney disease
prognostic factors
emergency department
machine learning
big data
patient reported